12:00 AM
May 17, 1999
 |  BC Week In Review  |  Company News  |  Deals

OraVax, Pasteur Merieux, Peptide Therapeutics deal

PTE completed its acquistion of ORVX for $3 million in cash and a $17 million purchase of 10 million new PTE shares (see BioCentury, Feb 1). The acquisition triggered the...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >